CTRI/2023/01/049263尚未招募2 期
Phase II Clinical Study to Evaluate Efficacy of Darvyadi Rasakriya In Sthula Pramehi on the Basis Of Ayurvedic Parameters with reference to Newly Diagnosed Type II Diabetes Mellitus
Aushadhi Bhavan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Newly diagnosed T2DM with any symptom of Polyuria, Polydipsia, Polyphagia, Bodyache, Giddiness, Polyneuritis, Fatigue and other symptoms mentioned in ayurvedic text
- •HbA1c 6.5 to 8.5
- •BMI More than 23
- •Subjects not taking any OHA
- •Subjects diagnosed within 2 years back
- •Subjects who agree to participate in the study and submit a written informed consent form
排除标准
- •Known Cases of type I DM
- •Patients of gestational diabetes
- •Any unstable Heart disease
- •Pregnant / Lactating women.
- •Alcoholics and/or drug abusers
- •Patients with evidence of malignancy
- •Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro, endocrinal disorders, etc.)
- •Patients who have completed participation in any other clinical trial during the past one (01) month.
- •Any other condition which the Investigator thinks may jeopardize the study
研究者
相似试验
未知
2 期
Phase 2 study of DS-8500aType 2 Diabetes MellitusJPRN-jRCT2080222546DAIICHISANKYO Co.,Ltd.90
进行中（未招募）
不适用
A phase II clinical trial on the combination of dabrafenib and trametinib for BRAF-inhibitor pretreated patients with advanced BRAF V600 mutant melanomaadvanced BRAF V600 mutant melanomaMedDRA version: 16.1Level: PTClassification code 10025671Term: Malignant melanoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: PTClassification code 10025670Term: Malignant melanoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: HLTClassification code 10027156Term: Skin melanomas (excl ocular)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: PTClassification code 10066600Term: Melanoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.1Level: PTClassification code 10027480Term: Metastatic malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-004966-33-BEZ Brussel
尚未招募
2 期
Efficacy of Unani Formulation in White PatchesCTRI/2022/04/041571Rajiv Gandhi University Of Health Sciences
尚未招募
不适用
Daratumumab plus DCEP for MM with plasmacytomaKCT0003345Seoul National University Hospital33
招募中
不适用
A clinical study to investigate the efficacy of diuretics to the HF patients with proteinuria and edema.Heart FailureJPRN-UMIN000006212Social Insurance Yokohama Central Hospital15